The adenovirus E4orf6 is a viral oncoprotein known to cooperate with the E1A gene product in transforming primary murine cells. It has been shown to inhibit the apoptotic activities of p53 and p73 through direct binding to these proteins. Here, we demonstrate that the adenovirus E4orf6 protein inhibits apoptosis mediated by BNIP3 and Bik, which are BH3-only proteins of the Bcl-2 family. This activity was not mediated by p53 and p73 because E4orf6 had the same effect on the apoptosis in Saos-2 cells that do not express p53-related genes. It was also ascertained that E4orf6 could change the mitochondrial localization of BNIP3 and Bik. A mutant lacking the nuclear export signal of E4orf6 failed to inhibit apoptosis and to translocate BNIP3 protein from the mitochondria. Moreover, it was also established that E4orf6 was able to interact with BNIP3 and Bik. In BNIP3 protein, the region required for the interaction included the transmembrane domain, which is required for the localization of BNIP3 to the mitochondria. These results suggest that E4orf6 is exported from the nucleus to the cytoplasm, enabling it to interact with BH3-only proteins, eventually leading to the inhibition of apoptotic activity.
Introduction
Apoptosis is an essential physiological process required for elimination of cells in multicellular organisms. It has distinctive morphological and biochemical features. In virus-infected cells, apoptotic events are initiated as a cellular defensive mechanism to eliminate infected cells . However, the viruses encode proteins that antagonize apoptosis to facilitate their propagation. Human adenovirus encodes such proteins in the E1B, E3 and E4 regions of the genome.
E4orf6 is one of the proteins coded in the E4 region, and is known as an oncogene product of the adenovirus. It cooperates with the E1A gene product to transform primary murine cells. Expression of E4orf6 markedly enhances the ability of transformed baby rat kidney (BRK) and human 293 cells to form tumors in nude mice (Moore et al., 1996; Nevels et al., 1997) . The E4orf6 protein binds to p53 and p73, and inhibits the ability of these proteins to activate transcription and to induce apoptosis (Dobner et al., 1996; Nevels et al., 1997; Higashino et al., 1998) . It is thought that E4orf6 targets p53 for active degradation through a proteasome (Moore et al., 1996; Nevels et al., 1997 Nevels et al., , 1998 Querido et al., 1997; Steegenga et al., 1998) . Recently, destabilization of p53 has been shown to contribute to E4orf6-mediated tumorigenesis (Nevels et al., 2000) . It has also been shown that the E1B-55kD/E4orf6 complex is involved in E3 ubiquitin ligase for ubiquitination of p53 (Querido et al., 2001) . However, little is known about any antiapoptotic function of E4orf6 that can counteract proapoptotic proteins except for p53-related gene products.
E4orf6 is also known to make a complex with the adenovirus E1B-55kD (Sarnow et al., 1984) . This complex is able to promote the nuclear export of viral mRNA and to contribute to the shutoff of cellular mRNA during the late phase of infection by adenovirus (Halbert et al., 1985; Weinberg and Ketner, 1986 ). E4orf6 has a functional nuclear export signal (NES) in the amino-terminal region (Dobbelstein et al., 1997) . It is essential for the ability of E4orf6 to shuttle between the nucleus and the cytoplasm.
The Bcl-2 family of proteins is well known to regulate apoptosis (Reed, 1995; Gross et al., 1999; Tsujimoto and Shimizu, 2000) . The members of the Bcl-2 family have been divided into antiapoptotic and proapoptotic groups. BNIP3 and Bik have been found as associated proteins of adenovirus E1B-19kD, which is a functional homolog of the Bcl-2 protein (Boyd et al., 1994 (Boyd et al., , 1995 . Since BNIP3 and Bik proteins share sequence homology with other members of the Bcl-2 family within the Bcl-2 homology (BH) 3 domain, these proteins have been recognized as members of the BH3-only protein family.
They also contain a transmembrane (TM) domain in the carboxyl-terminal region (Boyd et al., 1995; Yasuda et al., 1998) that appears to target these proteins to subcellular regions such as the mitochondria (Gross et al., 1999) . They can interact with Bcl-2 and Bcl-X L antiapoptotic proteins to modulate their functions (Boyd et al., 1995; Ray et al., 2000) . Recently, the BH3-only protein family has been recognized as a key initiator of apoptosis (Huang and Strasser, 2000) .
To further investigate the antiapoptotic activity of E4orf6, we examined whether E4orf6 expression affects the activity of cellular proteins that are key regulators of apoptotic progression. Here, we show that the adenovirus E4orf6 inhibits the apoptotic activities of the BH3-only proteins, BNIP3 and Bik. It was also established that E4orf6 can change the mitochondrial localization of these proteins and that the NES of E4orf6 is involved in these functions. All these findings strongly suggest that E4orf6 is transported from the nucleus to the cytoplasm to change the mitochondrial localization of BH3-only proteins.
Results

E4orf6 inhibits the apoptotic activity of BNIP3 and Bik
As a first step to understand the antiapoptotic activity of E4orf6 against the BH3-only proteins, we carried out a cell death assay using BNIP3 and Bik expression plasmids. First, 293 cells were cotransfected with hemagglutinin (HA) epitope-tagged BNIP3, b-galactosidase and/or E4orf6 expression plasmids. After 48 h, transfection of HA-BNIP3 into 293 cells resulted in apoptosis of about 60% of the cells, while the additional transfection of E4orf6 decreased the number of apoptotic cells in a dose-dependent manner (Figure 1a , left). The same results were obtained when a HA-Bik expression plasmid was used. HA-Bik induced about 80% apoptosis; however, the number of apoptotic cells was reduced upon E4orf6 expression (Figure 1a, right) .
To further confirm the ability of E4orf6 to inhibit apoptosis mediated by BNIP3 and Bik, we carried out a DNA fragmentation assay. HA-BNIP3 or HA-Bik transfected 293 cells showed nucleosome-sized DNA fragments. Conversely, the apoptotic DNA degradation patterns were not observed in DNA samples extracted from the 293 cells cotransfected with the E4orf6 expression plasmid (Figure 1b) . In the cells used for this assay, the expression levels of BNIP3 and Bik have never been altered by E4orf6 (Figure 1c ).
The Effect of E4orf6 is directed toward BNIP3 and Bik without intervention of p53-related gene products E4orf6 is known to interact with p53 and p73 proteins leading to inhibition of apoptotic activity (Dobner et al., 1996; Higashino et al., 1998) . We used Saos-2 cells, which do not express p53 and p73 (Chandar et al., 1992; Kaghad et al., 1997) , for cell death assays to examine whether the effect of E4orf6 for BH3-only proteins was mediated by p53-related gene products.
Saos-2 cells and two independent derivatives of Saos-2 cells expressing the E4orf6 protein (Higashino et al., 1998) were cotransfected with HA-BNIP3 and bgalactosidase expression plasmids. Two Saos-2 cell lines expressing E4orf6 protein (SaosE4x5 and SaosE4x11) were resistant to HA-BNIP3-mediated apoptosis (Figure 2a, left) . Although transfection of HA-BNIP3 into Saos-2 cells resulted in apoptosis of up to 50% of the cells, the rates of apoptosis in SaosE4 cells were 8-25%, and were proportional to the amount of the expression of E4orf6 in each cell line (Figure 2b ). The same results were obtained when Saos-2 cells were transfected with the HA-Bik expression plasmid. About 70% of the cells showed apoptosis, whereas the rate of apoptosis was reduced to about 20% when SaosE4x11 was used (Figure 2a, right) .
E4orf6 changes the localization of BNIP3 to the mitochondria
To determine the mechanism of the E4orf6 function against the BH3-only proteins, we observed the localization of these proteins. BNIP3 is known to be localized in E4orf6 inhibits apoptosis mediated by BH3-only protein M Aoyagi et al the mitochondria to act as an apoptotic molecule (Chen et al., 1997) and E4orf6 is able to shuttle between the nucleus and the cytoplasm (Goodrum et al., 1996; Dobbelstein et al., 1997; Fischer et al., 1999; Orlando and Ornelles, 1999; Dosch et al., 2001) . We examined whether the localization of BNIP3 and Bik could be altered in cells transfected with E4orf6. 293 cells were cotransfected with HA-BNIP3 and FLAG-E4orf6 expression plasmids. FLAG-E4orf6 protein was found in both the nucleus and the cytoplasm in the cells transfected with the FLAG-E4orf6 expression plasmid ( Figure 3a , E, K). We observed the same distribution of E4orf6 in SaosE4x11 cells ( Figure 3b , B, E). Since the HA-specific fluorescence was consistent with that of MitoTracker Red dye-stained cells, HA-BNIP3 and HA-Bik existed mainly in the mitochondria ( Figure 3a , A-C, G-I).
In cells expressing both FLAG-E4orf6 and HA-BNIP3, HA-BNIP3 was dispersed throughout the cytoplasm and not localized around the mitochondria (Figure 3a Usually, BH3-only protein expressing cells decrease their mitochondrial membrane potential Kim et al., 2002; Kubasiak et al., 2002) . To determine if E4orf6 changes the loss of the mitochondrial membrane potential mediated by BH3-only proteins, we used the Apoalert mitochondrial membrane sensor system in Saos-2 and SaosE4x11 cells. These cells were infected with Ad HA-BNIP3, stained with MitoSensor and analysed by laser confocal microscopy. In Saos-2 cell, MitoSensor remained as monomers in the cytoplasm and fluoresced green (Figure 3c, A) , whereas it aggregated in the mitochondria of SaosE4x11, and fluoresced red (Figure 3c, B) . These data suggest that E4orf6 inhibits the loss of mitochondrial membrane potential mediated by BNIP3 protein.
A nuclear export signal is required to change the localization of BNIP3 and to inhibit its apoptotic activity E4orf6 contains a NES and this motif was shown to be a prerequisite for the transport of E4orf6 from the nucleus to the cytoplasm. We constructed a mutant NES (E4orf6 NES (À)) by substituting two of the hydrophobic amino acids (L90 and I92) for alanine, which abolishes nucleocytoplasmic shuttling of E4orf6 (Figure 4a ) (Dobbelstein et al., 1997) . Immunofluorescence analysis using 293 cells showed that the E4orf6 NES (À) protein was localized only in the nucleus (Figure 4b, B) , and that the mutant had no ability to change the mitochondrial localization of HA-BNIP3 (Figure 4b , A, C).
Using E4orf6 NES (À), we examined the effect of the mutant against BNIP3-mediated apoptosis. About 60% of apoptotic activity mediated by HA-BNIP3 was not reduced upon the expression of E4orf6 NES (À), even if the amount of the plasmid was increased (Figure 5a ). DNA fragmentation assay showed the same result. The E4orf6 NES (À) failed to inhibit the fragmented DNA induced by HA-BNIP3 (Figure 5b) , although the expression level of HA-BNIP3 protein was not altered by E4orf6 NES (À) (Figure 5c ).
E4orf6 interacts with BNIP3 and the transmembrane domain of BNIP3 is important for the interaction
The fact that nuclear export is necessary to change the localization of the BH3-only proteins led us to test the interaction between E4orf6 and BH3-only proteins. E4orf6 and HA-BNIP3 expression plasmids were cotransfected into 293 cells and the cell lysate was immunoprecipitated with anti-HA antibody or normal rabbit serum. As shown in Figure 6a , E4orf6 was coprecipitated with HA-BNIP3. We also obtained the reverse result using anti-E4orf6 antibody for the immunoprecipitation. In order to confirm the binding in vitro, BNIP3 and Bik proteins were expressed as GST fusion proteins, and 35 S-labeled E4orf6 protein was mixed with immobilized GST-BNIP3, GST-Bik and GST alone as a control. After extensive washing, bound (Figure 6b ). E4orf6 appeared to bind to GST-BNIP3 and GST-Bik, whereas it did not bind to the control GST. These results indicate that E4orf6 binds to BNIP3 and Bik directly without being mediated by any other proteins.
To identify the region of BNIP3 required for the binding, we used deletion mutants of BNIP3 (Figure 6c ). BNIP3 has several conserved domains, which are shared by Bcl-2 family proteins (Yasuda et al., 1998) . BH3 is believed to be the death effector domain and is postulated to elicit cell death activity. The TM domain appears to target the Bcl-2 family proteins in subcellular regions such as the mitochondria (Gross et al., 1999) . GST-BNIP3 and its mutants were mixed with 35 Slabeled E4orf6 protein. BNIP3-DTM, a mutant lacking the carboxyl-terminal end including the TM domain, did not bind to E4orf6, although other derivatives did (Figure 6d ). The data suggest that E4orf6 interacts with the region including the TM domain of BNIP3.
Discussion
Our results showed that E4orf6 inhibited apoptosis mediated by the BH3-only proteins, BNIP3 and Bik. The same activities of E4orf6 also occurred in Saos-2 cells that do not express p53 and p73. An analysis of subcellular localization showed that E4orf6 was able to change the mitochondrial localization of BNIP3 and Bik. A substituted mutation in the NES of E4orf6 changed it to a form lacking inhibition of apoptosis and translocation of the BNIP3 protein. E4orf6 could interact directly with BNIP3 and Bik, and the region including the TM domain of BNIP3 was critical for the binding. These data indicate that the adenovirus E4orf6, which is exported from the nucleus to the cytoplasm, changed the localization of BH3-only proteins in order to inhibit their apoptotic activity.
Multiple signaling pathways are known to be involved in apoptosis. Bcl-2 family proteins such as Bax, PUMA 
Figure 4 Diagram and subcellular localization of E4orf6 mutant, E4orf6 NES (À). (a) Diagram of wild-type E4orf6 and E4orf6 NES (À). NES, CCR and Helix designate motifs in the E4orf6
protein that correspond to a nuclear export signal, a conserved cysteine-rich motif, and an arginine-rich amphipathic a helix, respectively. Substitution in the NES region is presented. (b) 293 cells were transfected with HA-BNIP3 and FLAG-E4orf6 NES (À) expression plasmids and were immunostained with each antibodies as described in Figure 3 E4orf6 inhibits apoptosis mediated by BH3-only protein M Aoyagi et al Higashino et al., 1998) , it was thought that the antiapoptotic activity of E4orf6 might be mediated by a reduction in the expression level of BH3-only proteins. However, as shown in Figure 1c , E4orf6 was not able to reduce the expression levels of BNIP3 and Bik proteins. In addition, E4orf6 appeared to suppress apoptotic activity mediated by BH3-only proteins in Saos-2 cells, in which p53-related proteins are not expressed. These results indicate that the inhibition is not mediated by p53-related gene products and that E4orf6 was able to inhibit apoptosis by directly affecting proapoptotic molecules. We conclude that E4orf6 can inhibit multiple apoptosis pathways. We observed that more than 50% of the cells showed unusual localization of BH3-only proteins when the cells were expressing E4orf6 protein in the cytoplasm. The expression of the E4orf6 NES (À) mutant, which is retained in the nucleus (Dobbelstein et al., 1997) , was not able to change the localization of BNIP3. These results indicate that the export of E4orf6 from the nucleus is necessary for transferring the BH3-only proteins from the mitochondria. Furthermore, the NES (À) mutant failed to inhibit apoptosis mediated by BNIP3. These results strongly suggest that one of the important functions of E4orf6 in inhibiting apoptosis is its ability to translocate BH3-only proteins from the mitochondria to the cytoplasm. These results are consistent with the fact that the mutant BNIP3, which failed to locate to the mitochondria, could not induce apoptosis (Chen et al., 1997) . Moreover, E4orf6 appeared to bind to the TM domain of BNIP3 (Figure 6d) , which is required for the localization of BNIP3 to mitochondria. Considering these results together, E4orf6 changes the localization of the BH3-only protein by interacting with the TM domain to prevent its localization to the mitochondria.
The permeabilization of mitochondrial membrane is essential for apoptosis. Loss of mitochondrial membrane potential is caused by mitochondrial transition pore opening and it leads to release of apoptogenic factor such as cytochrome c (Green and Reed, 1998; Gross et al., 1999) . BNIP3 is well known to decrease the mitochondrial membrane potential Kim et al., 2002; Kubasiak et al., 2002) . We found that E4orf6 inhibits the loss of mitochondrial membrane potential mediated by BNIP3 (Figure 2c) . From these data, we confirmed the antiapoptotic activity of E4orf6.
Interaction between E4orf6 and endogenous BNIP3 using 293 and BRK cells could not be observed, probably due to the low level of BNIP3 protien expression in these cells. Vande have shown that the expression of BNIP3 protein is very low in kidney cells. However, E4orf6 still has the potential to interact with BNIP3 due to the following reasons. First, the in vitro interaction assay indicates that E4orf6 bound to BNIP3 without any other mediating protein (Figure 6b) . Second, as E4orf6 appeared to bind to the TM domain of BNIP3 (Figure 6d ), which is required for the localizaton of BNIP3 to the mitochondria, the translocation of BNIP3 by the E4orf6 is a reasonable phenomenon. Third, E4orf6 was shown to interact with BNIP3 when both proteins were overexpressed in 293 cells (Figure 6a) . Fourth, the E4orf6 protein was present in the cytoplasm as earlier work has shown (Goodrum et al., 1996; Dobbelstein et al., 1997; Fischer et al., 1999; Orlando and Ornelles, 1999; Dosch et al., 2001) , therefore, there is a possibility for E4orf6 protein to interact with BNIP3 on the mitochondria. Whether the interaction is direct or indirect, our present study suggests that E4orf6 is able to change the localization of BH3-only proteins and inhibits their functions.
It is noteworthy that BNIP3 and Bik are targeted by two adenovirus oncoproteins, E1B-19kD and E4orf6. This makes it similar to the case of p53, which binds to both E1B-55kD and E4orf6 (Sarnow et al., 1982; Dobner et al., 1996) . BNIP3 and Bik were first identified by its ability to bind to the adenovirus E1B-19kD protein, which is a functional homolog of Bcl-2 antiapoptotic protein (Boyd et al., 1994) . Adenovirus gene products interact with key regulators of a number of cellular biological events; therefore, this fact is indicative of the biological significance of BH3-only proteins. E1B-19kD is thought to antagonize the activities of proapoptotic proteins via direct protein heterodimerization (Boyd et al., 1994 (Boyd et al., , 1995 and Dobbelstein, 2000) . These findings support the idea that the suppression of BH3-only proteins is also critical for adenovirus replication and transport of viral mRNA. The fate of BH3-only proteins after the translocation has still not been determined. Recently, it was reported that E4orf6 appeared to be involved in a cullincontaining E3 ubiquitin ligase that was capable of stimulating the ubiquitination of p53 (Querido et al., 2001) . On the other hand, ceBNIP3, the ortholog of BNIP3 in C. elegans, is known to be degraded by an ubiquitin-proteasome pathway . These raise the possibility that BNIP3 is degraded by an E4orf6-mediated ubiquitin-proteasome system. The fact that the proteolysis of p53 is performed in the cytoplasm supports this possibility, because translocated BNIP3 was in the cytoplasm as we demonstrated.
Materials and methods
Plasmids, cells and viruses
293, Cos-7 and Saos-2 cells were cultured in DMEM containing 10% fetal bovine serum. E4orf6-expressing Saos-2 cells (SaosE4x5 and SaosE4x11) were produced as described (Higashino et al., 1998) . E4orf6-substituted mutants were generated by site-directed mutagenesis (Quickchange; Stratagene). The BNIP3-deletion derivatives are described previously (Yasuda et al., 1998) . To construct GST-Bik expression plasmid, a cDNA fragment of Bik was amplified by PCR using Pfu DNA polymerase (Promega) then the fragment was cloned into the BamHI/EcoRI site of pGEX-5X-2 plasmid. The pRc/CMV-HA-BNIP3 and pRc/CMV-HA-Bik encoded HA-tagged BNIP3 and Bik proteins. Adenovirus vector expressing HA-BNIP3 (Ad HA-BNIP3) was constructed as described (Ishida et al., 2000) .
Apoptosis assays
For the cell death assay, 293, Saos-2, SaosE4x5 and SaosE4x11 cells were transfected with effector plasmids using FuGENE6 transfection reagent (Roche). The effector plasmids pcDNAE4orf6 (0.5-2 mg), pcDNA-E4orf6 NES (À) (0.5-2 mg), pRc/ CMV-HA-BNIP3 (1 mg) and pRc/CMV-HA-Bik (0.5 mg) were transfected with reporter pCMV-b-galactosidase (0.25 mg) plasmid. After 48 h, the cells were fixed with 0.5% glutaraldehyde, stained with X-gal as described (Yasuda et al., 1998) and microscopically scored.
For the DNA fragmentation assay, 293 cells were cotransfected with the expression plasmids of E4orf6 derivatives and pRc/CMV-HA-BNIP3 or pRc/CMV-HA-Bik using Fu-GENE6. After incubation for 48 h, adherent and floating cells were collected and resuspended in proteinase K lysis buffer (10 mm Tris-HCl, pH 8.0/5 mm EDTA/100 mm NaCl/1 mg/ml proteinase K/0.5% SDS). After proteinase K treatment, the lysates were incubated with RNase A, and then the samples were electrophoresed in 1% agarose gel.
Immunofluorescence
Indirect immunofluorescence studies were carried out using 293, Saos2 and SaosE4x11 cells plated on coverslips in 35-mm dishes. The 293 cells were cotransfected with pcDNA3-FlagE4orf6 (1 mg) and pRc/CMV-HA-BNIP3 or pRc/CMV-HABik (0.1 mg), utilizing FuGENE6. The Saos-2 and SaosE4x11 cells were infected with the Ad HA-BNIP3 at 25 PFU/cell or transfected with pRc/CMV-HA-Bik (1 mg) using FuGENE6. For mitochondrial staining, 25 nm of MitoTracker Red (Molecular Probes) was added to the media for 30 min at 24 h post-transfection. Cells were fixed with 4% formaldehyde, permeabilized with 100% methanol, and incubated with rat monoclonal anti-HA (3F10) antibody and mouse monoclonal anti-FLAG (M2) antibody or E4orf6-specific (RSAx3) mouse monoclonal antibody (Marton et al., 1990) , followed by FITCconjugated anti-rat and rhodamine-conjugated anti-mouse secondary antibodies as described (Yasuda et al., 1998) . Cells were observed using a Zeiss LSM510 confocal laser microscope.
Loss of mitochondrial membrane potential was measured by ApoAlertt Mitochondrial Membrane Sensor System (Clontech). Saos2 and SaosE4x11 cells plated on coverslips in 35-mm dishes were infected with Ad HA-BNIP3. After 48 h of infection, cells were stained with 5 mg/ml MitoSensor for 15 min and observed using a Zeiss LSM510 confocal laser microscope.
Protein interaction assays
To test for the interaction of E4orf6 and BNIP3, 293 cells were cotransfected with pCMV-E4orf6 and pRc/CMV-HA-BNIP3 expression plasmids (15 mg) by calcium phosphate-mediated transfection. After 24 h, the cells were lysed in the buffer (Harlow et al., 1986) containing 250 mm NaCl/50 mm HEPES, pH 7.0/0.1% Nonidet P-40 with protease inhibitor cocktails (Sigma) at the concentration that manufacturer recommended. Proteins were immunoprecipitated with a monoclonal anti-HA (12CA5) antibody or normal rabbit serum and the samples were subjected to Western blot using the RSAx3 and a chemiluminescence detection system (Amersham Pharamacia biotech). To test for the interaction of E4orf6 and BNIP3 or Bik in vitro,
35
S-methionine-labeled E4orf6 proteins were prepared by in vitro translation using a reticulocyte lysate system (Promega). The labeled proteins were incubated with GST-BNIP3 and GST-Bik immobilized on glutathioneagarose beads (Sigma) in NETN buffer (20 mm Tris, pH 8.0/ 100 mm NaCl/1 mm EDTA/0.5% Nonidet P-40). The beads were then washed five times in the same buffer, and the samples were subjected to SDS-PAGE. To test for the interaction of E4orf6 with the derivatives of BNIP3, GST-BNIP3 mutants were incubated with 35 S-methionine-labeled E4orf6 protein and the samples were pulled down using the same conditions.
